TERRI GINTHER: Open Payments
NPI 1447436175 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 57 payments from 11 companies in 2025. Trend: 2023 $796 · 2024 $1,013 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $414 |
| Vifor Pharma, Inc. | 9 | $216 |
| Ardelyx, Inc. | 4 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $136 |
| Calliditas Therapeutics US Inc. | 5 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Travere Therapeutics, Inc. | 3 | $66 |
| OPKO Pharmaceuticals, LLC | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Cycle Pharmaceuticals Inc | 1 | $26 |
Products named: Fabhalta, Veltassa, JARDIANCE, TARPEYO, XPHOZAH 30 MG, JYNARQUE, IBSRELA, RAYALDEE.
Industry payments across AL — which companies pay providers there.
